Optical Genome Mapping Market Outlook from 2024 to 2034

According to the recent research led by Future Market Insights, the global optical genome mapping market will attain a valuation of US$ 167.0 million by the year 2024. Projections indicate a subsequent increase to US$ 1.3 billion by 2034, demonstrating a significant growth trajectory. The expansion represents a CAGR of 23.5% during the forecast period.

Attributes Key Insights
Optical Genome Mapping Market Estimated Size in 2024 US$ 167.0 million
Projected Market Value in 2034 US$ 1.3 billion
Value-based CAGR from 2024 to 2034 23.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Market Motivators Enhancing Market Growth

  • Advancements in genomic research have led to the development of technologies that enable accurate and efficient mapping of genomes.
  • Increasing demand for personalized medicine facilitates the identification of genetic variations associated with diseases.
  • Cost effectiveness and efficiency lead to rapid analysis of large genomes with high accuracy, making them attractive for research and clinical applications.
  • Expansion of applications is driven by the need for accurate and comprehensive genomic analysis in clinical diagnostics, cancer research, and agriculture.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The optical genome mapping market expanded at a whopping 28.0% CAGR between 2019 and 2023. The global market is achieving heights to grow at a moderate CAGR of 23.5% over the forecast period 2024 to 2034.

The market saw a steady growth during the historical period, owing to advances in optical genome mapping technologies. Adoption of optical genome mapping in clinical settings expanded, driven by the need for comprehensive genomic analysis for disease diagnosis, treatment selection, and monitoring.

Increasing investments in genomic research and the rise of precision medicine had accelerated the demand for advanced genomic analysis tools, including optical genome mapping platforms.

Regulatory approvals and guidelines for optical genome mapping technologies facilitated market penetration and adoption in healthcare systems. Adoption of optical genome mapping in agriculture will increase, enabling precision breeding, crop improvement, and genetic resource conservation.

Integration with machine learning, big data analytics and AI will enhance data analysis capabilities, enabling deeper insights into genomic data and accelerating research and discovery. Efforts to expand market presence in emerging economies and regions with growing healthcare infrastructure will drive global market penetration and revenue growth.

Growing investments in genomics research, biotechnology, and healthcare infrastructure will fuel innovation, product development, and market expansion in the optical genome mapping sector.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Major Contributors of Optical Genome Mapping Market

  • Technological innovations are enhancing the capabilities of optical genome mapping platforms, improving their accuracy, throughput, and scalability.
  • Increasing Investment and Funding are fuelling the development and commercialization of optical genome mapping technologies.
  • Collaborations between academic institutions, research organizations, and biotechnology companies facilitate the sharing of resources.
  • Regulatory support and guidelines are enabling broader adoption and integration into healthcare systems.

Factors Hampering Optical Genome Mapping Market

  • High initial costs may deter adoption, especially among smaller research institutions, laboratories, and healthcare facilities with limited financial resources.
  • Lack of skilled personnel and computational resources for data analysis may pose a barrier to adoption.
  • Limited throughput and scalability may restrict the applicability of optical genome mapping in high throughput research and clinical settings.
  • Challenges in sample preparation may affect data accuracy and reproducibility, impacting the reliability and adoption of optical genome mapping technologies.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Advancements in Genome Research Will Create Opportunities in the United States

Country The United States
CAGR through 2034 23.8%

The optical genome mapping market in the United States will expand at a CAGR of 23.8% through 2034. The country is home to leading academic institutions, research organizations, and biotechnology companies at the forefront of genomic research.

Ongoing advancements in genomic technologies, including optical genome mapping, drive research innovation and stimulate market growth.

The United States is at the forefront of adopting precision medicine approaches, which rely on comprehensive genomic analysis to tailor medical treatments. Optical genome mapping technologies play a crucial role in this paradigm shift by providing high resolution analysis of genomes.

Strong Academic and Research Institutions to Enhance the Market Growth in the United Kingdom

Country The United Kingdom
CAGR through 2034 24.7%

The optical genome mapping market in the United Kingdom to expand at a CAGR of 24.7% through 2034. The country is home to renowned academic and research institutions with expertise in genomics and molecular biology.

Collaboration between academia, industry, and healthcare providers fosters innovation, technology development, and translation of research findings.

The United Kingdom has made significant investments in genomic medicine initiatives, such as the 100,000 Genomes Project and the Genomics England program. Government support for genomic research and healthcare infrastructure drives the adoption of advanced genomic technologies like optical genome mapping.

Biotechnology Innovation Will Augment the Market Prospects in China

Country China
CAGR through 2034 24.4%

Optical genome mapping trends in China are taking a turn for the better. A 24.4% CAGR is forecast for the country from 2024 to 2034. The country has a rapidly growing biotechnology ecosystem with a strong focus on innovation and entrepreneurship.

Biotechnology start-ups and companies in China leverage government support, and access to capital to commercialize advanced genomic technologies.

China is investing in modernizing its healthcare infrastructure and implementing precision medicine initiatives. Integration of genomic technologies, including optical genome mapping, into clinical practice and healthcare delivery systems to fuel the market growth.

Research Funding and Support to Stimulate the Market Growth in Japan

Country Japan
CAGR through 2034 25.4%

The optical genome mapping market in Japan is poised to expand at a CAGR of 25.4% through 2034. The country provides research funding and support for genomic research and technology development.

Research grants, funding initiatives, and academic industry collaborations stimulate innovation, drive technology adoption. Japan actively collaborates with international partners in genomic research, healthcare, and industry.

Collaborative initiatives and partnerships enable knowledge exchange, technology transfer, and market expansion, driving growth opportunities.

Focus on Cancer Genomics to Accelerate the Market Aspects in Korea

Country Korea
CAGR through 2034 26.0%

The optical genome mapping market in Korea will expand at a CAGR of 26.0% through 2034. The country has a high incidence of cancer and is actively engaged in cancer genomics research and precision oncology initiatives.

Optical genome mapping technologies enable comprehensive profiling of tumor genomes, identification of driver mutations, and characterization of tumor heterogeneity.

Korea has been an early adopter of next generation sequencing technologies for genomic research and clinical applications. Optical genome mapping complements NGS by providing high resolution structural variation analysis.

Category-wise Insights

The below table highlights how instruments segment is leading the market in terms of component, and will account for a CAGR of 23.2% through 2034. Based on application, the research segment is gaining heights and will to account for a CAGR of 23.0% through 2034.

Category CAGR through 2034
Instruments 23.2%
Research 23.0%

Instruments Segment Witnesses High Demand for Optical Genome Mapping

Based on component, the instruments segment will dominate the optical genome mapping market. Increasing investments in genomic research and biotechnology drive the demand for instruments used in optical genome mapping.

Research institutions, academic laboratories, and biotechnology companies invest in advanced instruments to support their genomic research initiatives. The integration of optical genome mapping into clinical diagnostics drives demand for instruments suitable for use in healthcare settings.

Instruments capable of processing clinical samples, providing accurate and reliable results, and meeting regulatory requirements for diagnostic use are in high demand.

Research Segment to Hold High Demand for Optical Genome Mapping

In terms of application, the research segment will dominate the optical genome mapping market. Optical genome mapping is particularly valuable for the analysis of complex genomes, including large and repetitive regions that are challenging to analyze using other genomic technologies.

Researchers studying complex organisms, such as plants, animals, and microorganisms, rely on optical genome mapping to unravel the complexities of their genomes. Optical genome mapping offers high resolution analysis of structural variations in genomes, such as insertions, deletions, duplications, and translocations.

There is a growing demand for optical genome mapping in structural variation analysis, with increasing recognition of the importance of structural variations in disease pathogenesis and population genetics.

Competitive Landscape

The competitive landscape of the optical genome mapping market is dynamic and evolving, characterized by the presence of established players, emerging companies, and technological advancements driving innovation and market growth.

Company Portfolio

  • Bionano Genomics, Inc. is a leading provider of optical genome mapping solutions for genomic analysis. The flagship product of the company, the Saphyr system, offers high throughput optical genome mapping for structural variation analysis.
  • Nucleome Informatics Private Limited is a biotechnology company specializing in computational genomics and genomic data analysis. They offer advanced bioinformatics tools and software solutions for analyzing optical genome mapping data.

Key Coverage in the Optical Genome Mapping Industry Report

  • Optical Genome Mapping technology
  • Genomic analysis solutions
  • Structural variation detection
  • High-resolution DNA mapping
  • Next-generation genome sequencing
  • Optical Genome Mapping Market
  • Next-Generation Sequencing Market
  • Molecular Diagnostics Market

Report Scope

Attribute Details
Estimated Market Size in 2024 US$ 167.0 million
Projected Market Valuation in 2034 US$ 1.3 billion
Value-based CAGR 2024 to 2034 23.5%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ Million
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key Market Segments Covered
  • Component
  • Application
  • Solution
  • End Use
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • Bionano Genomics Inc.
  • Nucleome Informatics Private Limited
  • Nabsys Inc.
  • Praxis Genomics LLC
  • PerkinElmer Inc.
  • OpGen Inc.
  • SourceBio International Limited
  • MedGenome Labs Private Limited
  • Genohub Inc.
  • Cerba HealthCare

Segmentation Analysis of the Optical Genome Mapping Market

By Component:

  • Instruments
  • Consumables and Reagents
  • Services and Software

By Application:

  • Research
  • Diagnostics

By Solution:

  • Structural Variant Detection
  • Genome Assembly
  • Microbial Strain Typing
  • Other Solutions

By End Use:

  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Diagnostic Laboratories
  • Other End Users

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Frequently Asked Questions

What is the anticipated value of the Optical Genome Mapping market in 2024?

The optical genome mapping market is projected to reach a valuation of US$ 167.0 million in 2024.

What is the expected CAGR for the Optical Genome Mapping market until 2034?

The optical genome mapping industry is set to expand by a CAGR of 23.5% through 2034.

How much valuation is projected for the Optical Genome Mapping market in 2034?

The optical genome mapping market is forecast to reach US$ 1.3 billion by 2034.

Which country is projected to lead the Optical Genome Mapping market?

Korea is set to be the top performing market, exhibiting a CAGR of 26.0% through 2034.

Which is the dominant component in the Optical Genome Mapping domain?

Instruments segment is preferred, and will account for a CAGR of 23.2% through 2034.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034
        5.3.1. Instruments
        5.3.2. Consumables & Reagents
        5.3.3. Services & Software
    5.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023
    5.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
        6.3.1. Research
        6.3.2. Diagnostics
    6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
    6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Solution
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Solution, 2019 to 2023
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Solution, 2024 to 2034
        7.3.1. Structural Variant Detection
        7.3.2. Genome Assembly
        7.3.3. Microbial Strain Typing
        7.3.4. Other Solutions
    7.4. Y-o-Y Growth Trend Analysis By Solution, 2019 to 2023
    7.5. Absolute $ Opportunity Analysis By Solution, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2019 to 2023
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2024 to 2034
        8.3.1. Pharmaceutical & Biotechnology Companies
        8.3.2. Research & Academic Institutes
        8.3.3. Diagnostic Laboratories
        8.3.4. Other End-Users
    8.4. Y-o-Y Growth Trend Analysis By End-use, 2019 to 2023
    8.5. Absolute $ Opportunity Analysis By End-use, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. South Asia and Pacific
        9.3.6. East Asia
        9.3.7. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        10.2.1. By Country
            10.2.1.1. USA
            10.2.1.2. Canada
        10.2.2. By Component
        10.2.3. By Application
        10.2.4. By Solution
        10.2.5. By End-use
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Component
        10.3.3. By Application
        10.3.4. By Solution
        10.3.5. By End-use
    10.4. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Component
        11.2.3. By Application
        11.2.4. By Solution
        11.2.5. By End-use
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Component
        11.3.3. By Application
        11.3.4. By Solution
        11.3.5. By End-use
    11.4. Key Takeaways
12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. UK
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Rest of Western Europe
        12.2.2. By Component
        12.2.3. By Application
        12.2.4. By Solution
        12.2.5. By End-use
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Component
        12.3.3. By Application
        12.3.4. By Solution
        12.3.5. By End-use
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        13.2.1. By Country
            13.2.1.1. Poland
            13.2.1.2. Russia
            13.2.1.3. Czech Republic
            13.2.1.4. Romania
            13.2.1.5. Rest of Eastern Europe
        13.2.2. By Component
        13.2.3. By Application
        13.2.4. By Solution
        13.2.5. By End-use
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Component
        13.3.3. By Application
        13.3.4. By Solution
        13.3.5. By End-use
    13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        14.2.1. By Country
            14.2.1.1. India
            14.2.1.2. Bangladesh
            14.2.1.3. Australia
            14.2.1.4. New Zealand
            14.2.1.5. Rest of South Asia and Pacific
        14.2.2. By Component
        14.2.3. By Application
        14.2.4. By Solution
        14.2.5. By End-use
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Component
        14.3.3. By Application
        14.3.4. By Solution
        14.3.5. By End-use
    14.4. Key Takeaways
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        15.2.1. By Country
            15.2.1.1. China
            15.2.1.2. Japan
            15.2.1.3. South Korea
        15.2.2. By Component
        15.2.3. By Application
        15.2.4. By Solution
        15.2.5. By End-use
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Component
        15.3.3. By Application
        15.3.4. By Solution
        15.3.5. By End-use
    15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Israel
            16.2.1.4. Rest of MEA
        16.2.2. By Component
        16.2.3. By Application
        16.2.4. By Solution
        16.2.5. By End-use
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Component
        16.3.3. By Application
        16.3.4. By Solution
        16.3.5. By End-use
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. USA
        17.1.1. Market Share Analysis, 2023
            17.1.1.1. By Component
            17.1.1.2. By Application
            17.1.1.3. By Solution
            17.1.1.4. By End-use
    17.2. Canada
        17.2.1. Market Share Analysis, 2023
            17.2.1.1. By Component
            17.2.1.2. By Application
            17.2.1.3. By Solution
            17.2.1.4. By End-use
    17.3. Brazil
        17.3.1. Market Share Analysis, 2023
            17.3.1.1. By Component
            17.3.1.2. By Application
            17.3.1.3. By Solution
            17.3.1.4. By End-use
    17.4. Mexico
        17.4.1. Market Share Analysis, 2023
            17.4.1.1. By Component
            17.4.1.2. By Application
            17.4.1.3. By Solution
            17.4.1.4. By End-use
    17.5. Germany
        17.5.1. Market Share Analysis, 2023
            17.5.1.1. By Component
            17.5.1.2. By Application
            17.5.1.3. By Solution
            17.5.1.4. By End-use
    17.6. UK
        17.6.1. Market Share Analysis, 2023
            17.6.1.1. By Component
            17.6.1.2. By Application
            17.6.1.3. By Solution
            17.6.1.4. By End-use
    17.7. France
        17.7.1. Market Share Analysis, 2023
            17.7.1.1. By Component
            17.7.1.2. By Application
            17.7.1.3. By Solution
            17.7.1.4. By End-use
    17.8. Spain
        17.8.1. Market Share Analysis, 2023
            17.8.1.1. By Component
            17.8.1.2. By Application
            17.8.1.3. By Solution
            17.8.1.4. By End-use
    17.9. Italy
        17.9.1. Market Share Analysis, 2023
            17.9.1.1. By Component
            17.9.1.2. By Application
            17.9.1.3. By Solution
            17.9.1.4. By End-use
    17.10. Poland
        17.10.1. Market Share Analysis, 2023
            17.10.1.1. By Component
            17.10.1.2. By Application
            17.10.1.3. By Solution
            17.10.1.4. By End-use
    17.11. Russia
        17.11.1. Market Share Analysis, 2023
            17.11.1.1. By Component
            17.11.1.2. By Application
            17.11.1.3. By Solution
            17.11.1.4. By End-use
    17.12. Czech Republic
        17.12.1. Market Share Analysis, 2023
            17.12.1.1. By Component
            17.12.1.2. By Application
            17.12.1.3. By Solution
            17.12.1.4. By End-use
    17.13. Romania
        17.13.1. Market Share Analysis, 2023
            17.13.1.1. By Component
            17.13.1.2. By Application
            17.13.1.3. By Solution
            17.13.1.4. By End-use
    17.14. India
        17.14.1. Market Share Analysis, 2023
            17.14.1.1. By Component
            17.14.1.2. By Application
            17.14.1.3. By Solution
            17.14.1.4. By End-use
    17.15. Bangladesh
        17.15.1. Market Share Analysis, 2023
            17.15.1.1. By Component
            17.15.1.2. By Application
            17.15.1.3. By Solution
            17.15.1.4. By End-use
    17.16. Australia
        17.16.1. Market Share Analysis, 2023
            17.16.1.1. By Component
            17.16.1.2. By Application
            17.16.1.3. By Solution
            17.16.1.4. By End-use
    17.17. New Zealand
        17.17.1. Market Share Analysis, 2023
            17.17.1.1. By Component
            17.17.1.2. By Application
            17.17.1.3. By Solution
            17.17.1.4. By End-use
    17.18. China
        17.18.1. Market Share Analysis, 2023
            17.18.1.1. By Component
            17.18.1.2. By Application
            17.18.1.3. By Solution
            17.18.1.4. By End-use
    17.19. Japan
        17.19.1. Market Share Analysis, 2023
            17.19.1.1. By Component
            17.19.1.2. By Application
            17.19.1.3. By Solution
            17.19.1.4. By End-use
    17.20. South Korea
        17.20.1. Pricing Analysis
            17.20.1.1. By Component
            17.20.1.2. By Application
            17.20.1.3. By Solution
            17.20.1.4. By End-use
    17.21. GCC Countries
        17.21.1. Pricing Analysis
            17.21.1.1. By Component
            17.21.1.2. By Application
            17.21.1.3. By Solution
            17.21.1.4. By End-use
    17.22. South Africa
        17.22.1. Market Share Analysis, 2023
            17.22.1.1. By Component
            17.22.1.2. By Application
            17.22.1.3. By Solution
            17.22.1.4. By End-use
    17.23. Israel
        17.23.1. Market Share Analysis, 2023
            17.23.1.1. By Component
            17.23.1.2. By Application
            17.23.1.3. By Solution
            17.23.1.4. By End-use
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Component
        18.3.3. By Application
        18.3.4. By Solution
        18.3.5. By End-use
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Bionano Genomics, Inc.
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
        19.1.2. Nucleome Informatics Private Limited
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
        19.1.3. Nabsys, Inc.
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
        19.1.4. Praxis Genomics LLC
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
        19.1.5. PerkinElmer, Inc.
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
        19.1.6. OpGen, Inc.
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
        19.1.7. SourceBio International Limited
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
        19.1.8. MedGenome Labs Private Limited
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
        19.1.9. Genohub Inc.
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
        19.1.10. Cerba HealthCare
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Recommendations

Healthcare

Gene Editing Tool Market

May 2024

REP-GB-9544

324 pages

Healthcare

Whole Genome Amplification Market

May 2024

REP-GB-1873

324 pages

Healthcare

Genome Editing Market

February 2024

REP-GB-19118

300 pages

Healthcare

Personal Genome Testing Market

July 2022

REP-GB-4206

323 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Optical Genome Mapping Market

Schedule a Call